Literature DB >> 28857781

Dolutegravir and neuropsychiatric adverse events: a continuing debate.

Johann Cailhol1, Cécile Rouyer, Chakib Alloui, Vincent Jeantils.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28857781     DOI： 10.1097/QAD.0000000000001596

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

Review 1.  Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection.

Authors:  Francis J Zamora; Ellen Dowers; Faiza Yasin; Onyema Ogbuagu
Journal:  HIV AIDS (Auckl)       Date:  2019-10-23

2.  Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016.

Authors:  Ignacio Perez Valero; Alfonso Cabello; Pablo Ryan; Sara De La Fuente-Moral; Ignacio Santos; Maria Jesus Vivancos; Alicia Gonzalez; Miguel Gorgolas; Guillermo Cuevas; Alberto Diaz De Santiago; Joanna Cano; Guadalupe Rua; Maria Yllescas; Juan Julian González García
Journal:  Open Forum Infect Dis       Date:  2020-10-18       Impact factor: 3.835

3.  Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418.

Authors:  Alfonso Cabello-Úbeda; Alicia González Baeza; Jesús Troya García; Sara de La Fuente Moral; María Novella Mena; Adriana Pinto Martínez; Rafael Micán; Miguel Górgolas; Guillermo Cuevas Tascón; Alberto Díaz de Santiago; José Sanz Morerno; David Rial Crestelo; Carmen Busca Arenzana; José Ignacio Bernardino Serna; Mariana Díaz Almirón; Joanna Cano; Herminia Esteban; Ignacio Pérez-Valero
Journal:  Open Forum Infect Dis       Date:  2022-08-06       Impact factor: 4.423

Review 4.  Update on Adverse Effects of HIV Integrase Inhibitors.

Authors:  Agnieszka Kolakowska; Anaenza Freire Maresca; Intira Jeannie Collins; Johann Cailhol
Journal:  Curr Treat Options Infect Dis       Date:  2019-11-16

5.  Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV.

Authors:  Lisa Van de Wijer; Wouter van der Heijden; Mike van Verseveld; Mihai Netea; Quirijn de Mast; Arnt Schellekens; André van der Ven
Journal:  AIDS Behav       Date:  2021-04-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.